However, when patients with rheumatoid arthritis, whose mortality is associated with IR‐associated metabolic disorder, were treated with a TNF inhibitor, it significantly improved their insulin response, implying that TNF action is more complex in clinical contexts. The gene discussed is TNF; the disease is Other metabolic disease.